Use and effects of cannabinoids in military veterans with posttraumatic stress disorder
- 1 August 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 72 (15), 1279-1284
- https://doi.org/10.2146/ajhp140523
Abstract
Purpose Published evidence regarding the use of cannabis and cannabis derivatives by military veterans with posttraumatic stress disorder (PTSD) is reviewed. Summary When inhaled or delivered orally or transdermally, cannabinoids (the psychoactive components of unrefined marijuana and various derivative products) activate endogenous cannabinoid receptors, modulating neurotransmitter release and producing a wide range of central nervous system effects, including increased pleasure and alteration of memory processes. Those effects provide a pharmacologic rationale for the use of cannabinoids to manage the three core PTSD symptom clusters: reexperiencing, avoidance and numbing, and hyperarousal. A literature search identified 11 articles pertaining to cannabis use by military veterans who met standard diagnostic criteria for PTSD. Cross-sectional studies have found a direct correlation between more severe PTSD symptomatology and increased motivation to use cannabis for coping purposes, especially among patients with difficulties in emotional regulation or stress tolerance. Data from 4 small studies suggested that cannabinoid use was associated with global improvements in PTSD symptoms or amelioration of specific PTSD symptoms such as insomnia and nightmares. Large well-designed controlled trials are needed in order to better delineate the potential role of cannabinoids as an adjunct or alternative to conventional approaches to PTSD management. Conclusion While further research into cannabinoid treatment effects on PTSD symptoms is required, the evaluated evidence indicates that substantial numbers of military veterans with PTSD use cannabis or derivative products to control PTSD symptoms, with some patients reporting benefits in terms of reduced anxiety and insomnia and improved coping ability.Keywords
This publication has 15 references indexed in Scilit:
- The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD)Frontiers in Behavioral Neuroscience, 2013
- Prospective investigation of the impact of cannabis use disorders on posttraumatic stress disorder symptoms among veterans in residential treatment.Psychological Trauma: Theory, Research, Practice, and Policy, 2013
- Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.Psychology of Addictive Behaviors, 2011
- Posttraumatic stress and marijuana use coping motives: The mediating role of distress toleranceJournal of Anxiety Disorders, 2011
- Posttraumatic Stress, Difficulties in Emotion Regulation, and Coping-Oriented Marijuana UseCognitive Behaviour Therapy, 2011
- The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)CNS Neuroscience & Therapeutics, 2009
- Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event‐exposed marijuana usersJournal of Traumatic Stress, 2007
- Medical marijuana and the developing role of the pharmacistAmerican Journal of Health-System Pharmacy, 2007
- The Epidemiology of Post-Traumatic Stress Disorder after DisastersEpidemiologic Reviews, 2005
- Post-Traumatic Stress DisorderNew England Journal of Medicine, 2002